4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-021154
INTERIM PRESIDENT AND CEO acquired 43,548 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-08-09 | Option exercise | +43,548 | $0.72 | $31,355 | 1,356,153 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-08-09 | Option exercise · Employee Stock Option (right to buy) | −43,548 | 0 | D: show line 2 in the form |
Loading xslF345X05/form4-08132024_040801.xml…